Navigation Links
Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
Date:8/8/2008

ASHBURN, Va., Aug. 8 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of three ongoing phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the management of post-operative pain.

Innocoll's BUPIVACAINE SURGICAL IMPLANT is a biodegradable and fully bioresorbable matrix of purified fibrillar collagen impregnated with the local anesthetic, bupivacaine, which has been specifically developed and formulated using Innocoll's proprietary CollaRx sponge technology. It is under development in the US and Europe for the management of post-operative pain following moderate/major abdominal, gynecological, abdominal, thoracic, and orthopedic surgeries.

Post-operative pain is typically controlled with narcotic analgesics such as morphine, but systemic administration of these drugs can result in unfavorable side effects including suppression of breathing, sedation, nausea and vomiting, and can also affect patient recovery. Innocoll's BUPIVACAINE SURGICAL IMPLANT is intended to provide pain control directly at the surgical site and thus reduce the level of additional analgesia required following surgery. The collagen matrix naturally biodegrades over a few days and the bupivacaine is released to provide local analgesia for up to 96 hours post-operatively. A key feature of Innocoll's product is the ability to implant it directly into the surgical cavity and at different layers within the wound, such as across the peritoneal incision and directly below the skin incision, which enables localized treatment of both the incisional and deep, visceral pain components normally associated with moderate and major surgery. The bioresorbable nature of the collagen matrix also offers significant clinical benefits and convenience advantages over ambulatory infusion pumps which can be used to pro
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
3. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
7. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
10. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
11. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, United States Dental Devices Market Anal...rtlinker.com/p0158733/United-States-Dental-Devices... United States Dental Devices Market Analysis and ...t is an essential source for in-depth information ...
(Date:11/25/2009)... According to Millennium Research ...ology market intelligence, the nearly $3 billion U... to see rapid growth over the next five years desp...s for Trauma Devices 2010 report finds that thi...five years, with competitors introducing specializ...
(Date:11/25/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Intranasal Drug Delivery - US Market Tre...0164267/Intranasal-Drug-Delivery---US-Market-Trend...ivery market is witnessing an expansion of therape...l local therapeutic drugs to the delivery of syste...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Metabolife 28R 29 Reminds Us That the Little Things We Do Can Bring Positive Change to Our Lives and the Lives of Others 53228 1Metabolife 28R 29 Reminds Us That the Little Things We Do Can Bring Positive Change to Our Lives and the Lives of Others 53228 2CVS pharmacy Enhancing Accessibility for the Visually Impaired To Its Web Site and Store Point of Sales Devices 53227 1CVS pharmacy Enhancing Accessibility for the Visually Impaired To Its Web Site and Store Point of Sales Devices 53227 2CVS pharmacy Enhancing Accessibility for the Visually Impaired To Its Web Site and Store Point of Sales Devices 53227 3CVS pharmacy Enhancing Accessibility for the Visually Impaired To Its Web Site and Store Point of Sales Devices 53227 4Chinese women join global breast cancer trial 53225 1Chinese women join global breast cancer trial 53225 2
...s Novel Technology in Treatment of Chronic Atrial ...RLSBAD, Calif., Jan. 16 Ablation Frontiers, Inc.,... first ever U.S.,Investigational Device Exemption ...of chronic atrial fibrillation (AF). Approval from...eed with the pivotal phase of the,study is based o...
...a Biopharmaceuticals Plc, a,biopharmaceutical comp...ammatory drugs, today announced the preliminary sa...ity study of MRX-4 in 16 patients suffering,from a...tered as a single dose once a week for four,consec...thout a nasal,allergen challenge (NAC) while the s...
Other Medicine Technology:FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial 2FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial 3Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients 2
(Date:11/26/2009)..., The copper sequestering drug tetrathiomolybdate... the treatment of Wilson disease, a disease caused...cancers. That much is known. Very little, however,...r level. , A new study led by Northwestern Unive...lue: the three-dimensional structure of TM bound t...
(Date:11/26/2009)..., No more letters from th...or,personalized text messages from Santa , ...effort to increase operational efficiencies at the...ng to help keep children all over the globe inform... ,Elves in Santa’s research department have ...
(Date:11/26/2009)..., Benton Communications a...iness growth system for retailers struggling to ma... (PRWEB) November 26, 2009 -- Flu fears is the ty...es to the emergency room, according to Dr. David B...wly released business growth system – The R...
(Date:11/25/2009)..., , KANSAS CITY, Mo., Nov. 25 /PRNewswir...rarily become the nation,s largest medical clinic ... a series of massive free clinics for uninsured pe...ial to be the biggest one yet, because it will ext...on weekdays instead of over a weekend," Sheri Wood...
(Date:11/25/2009)..., , TORONTO, Nov. 25 /PRNewswire/ - Senti...st MRI coils and advanced visualization software l...cations on its Aegis(TM) medical imaging software ...rth America (RSNA) annual meeting in Chicago, Nov....cations leverage the unique high quality images ge...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...lects Robust Growth of Client Intuitive Surgical,s...April 21 The Chamberlain Group, producers of anat...ed their new Uterine Robotic Surgery Trainer. , ,... feels like living tissue, has appropriate elastic...
...T WORTH, Texas, April 21 Wound Care Innovations, ..., Inc., (OTC Bulletin Board: WNDM), announced toda...Xenos Partners, LLC (QX Partners) to market and di...mall Business (SDVOB) that provides expertise and ...
...STON, April 21 More people are turning to a new t...ion - tattooing. A case report will be presented ...nical Endocrinologists (AACE) 18th Annual Meeting ...om/cgi-bin/prnh/20090324/DC88061LOGO-b ) , , One ...
... Ohio State University Medical Center Implants T...t Assist System Under FDA-Approved Clinical Trial ...e Heart (ASX: SHC), a global medical device compan...completed the first two implants of the Company,s ...
...m denial to missing important details: A new surve...dult children can suffer when a parent has a heari...nction with Better Hearing and Speech Month in May...rent,s relationship with their adult children. Ene...
... , AUSTIN, Texas, April 21 Bates County Memori...ted in Butler, MO and serving Bates County and sur...ions, Inc. to implement the OpusClinicalSuite(R) E...aternity care, with extensive outpatient specialty...
Other Medicine News:Health News:Chamberlain Group Announces New Uterine Robotic Surgery Training Device 2Health News:Chamberlain Group Announces New Uterine Robotic Surgery Training Device 3Health News:Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC 2Health News:Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC 3Health News:New Research Reveals Need for Doctors to Know About Medical Tattoos 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 2Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 3Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 4Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 5Health News:Bates County Memorial Hospital Selects Opus Healthcare Solutions, Inc. to Implement the OpusClinicalSuite(R) EMR 2Health News:Bates County Memorial Hospital Selects Opus Healthcare Solutions, Inc. to Implement the OpusClinicalSuite(R) EMR 3
Miami Hip Orthosis
Boston Post-Op Hip Orthosis
... significant advance in walker design in years. A ...e weight bearing surfaces of the foot rest on adap...the heel strike. The footbed in the sole conforms ... and stability. , ,No leg length discrepancy; Hee...
...rovides comfortable stability for acute ankle spra... fractures of the lower leg and ankle, and stable ...er are available to accommodate larger patients.Th...s ideal for acute ankle sprains, forefoot and midf...
Medicine Products: